Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria
· Delayed Price · Currency is NGN 2.780
0.00 (0.00%)
At close: Apr 24, 2025
NGX:NEIMETH Revenue
In the year 2024, Neimeth International Pharmaceuticals had annual revenue of 4.47B NGN with 102.23% growth. Neimeth International Pharmaceuticals had revenue of 1.37B in the quarter ending December 31, 2024, with 96.69% growth.
Revenue
4.47B
Revenue Growth
+102.23%
P/S Ratio
2.66
Revenue / Employee
22.12M
Employees
202
Market Cap
11.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.47B | 2.26B | 102.23% |
| Dec 31, 2023 | 2.21B | -709.73M | -24.31% |
| Dec 31, 2022 | 2.92B | 216.47M | 8.01% |
| Sep 30, 2022 | 2.70B | -343.81M | -11.28% |
| Sep 30, 2021 | 3.05B | 207.54M | 7.31% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dangote Cement | 3,580.55B |
| BUA Foods | 1,527.92B |
| MTN Nigeria Communications | 3,360.83B |
| Geregu Power | 118.46B |
| BUA Cement | 876.47B |
| Transcorp Power | 305.94B |
| Aradel Holdings | 581.15B |
| Zenith Bank | 2,203.99B |